MilliporeSigma

MilliporeSigma is a global powerhouse in the life science tools and bioprocessing sector, formed from the merger of Millipore and Sigma-Aldrich. It serves two primary markets: the scientific research community with one of the industry's broadest product portfolios, and the biopharmaceutical industry with essential products and integrated services for drug development and manufacturing. As a key subsidiary of the multinational Merck KGaA, it leverages significant scale and R&D investment to maintain a leading position. Its strategy is centered on enabling scientific discovery and accelerating the translation of research into therapies, particularly in high-growth areas like cell and gene therapy.

Integrated provider of life science tools, bioprocessing products (cell culture, filtration, chromatography), and contract services (testing, CDMO) for research and biopharmaceutical manufacturing.

Operates in a highly competitive and consolidated market. Primary competitors include Thermo Fisher Scientific, Danaher (through its Cytiva and Pall businesses), and Agilent Technologies. Competition is based on product portfolio breadth, technological innovation, price, supply reliability, and the quality of technical support and services.